Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

129.00p
   
  • Change Today:
    -4.00p
  • 52 Week High: 150.00
  • 52 Week Low: 108.00
  • Currency: UK Pounds
  • Shares Issued: 84.81m
  • Volume: 101,152
  • Market Cap: £109.40m
  • RiskGrade: 196
  • Beta: 0.00

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
73.15% above the market average73.15% above the market average73.15% above the market average73.15% above the market average73.15% above the market average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
13.14% above the market average13.14% above the market average13.14% above the market average13.14% above the market average13.14% above the market average
41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average
Price Book Ratio
56.23% below the market average56.23% below the market average56.23% below the market average56.23% below the market average56.23% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
40.90% above the market average40.90% above the market average40.90% above the market average40.90% above the market average40.90% above the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average
Price Chg 3m
48.73% below the market average48.73% below the market average48.73% below the market average48.73% below the market average48.73% below the market average
13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
2.03% above the market average2.03% above the market average2.03% above the market average2.03% above the market average2.03% above the market average
2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average
Momentum 20
37.30% above the market average37.30% above the market average37.30% above the market average37.30% above the market average37.30% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
51.21% below the market average51.21% below the market average51.21% below the market average51.21% below the market average51.21% below the market average
3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
66.25% below the market average66.25% below the market average66.25% below the market average66.25% below the market average66.25% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
10.94% below the market average10.94% below the market average10.94% below the market average10.94% below the market average10.94% below the market average
21.21% above the sector average21.21% above the sector average21.21% above the sector average21.21% above the sector average21.21% above the sector average
Operating Profit Loss
61.06% below the market average61.06% below the market average61.06% below the market average61.06% below the market average61.06% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
2.62% above the market average2.62% above the market average2.62% above the market average2.62% above the market average2.62% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Cash
15.36% above the market average15.36% above the market average15.36% above the market average15.36% above the market average15.36% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
18.55% above the market average18.55% above the market average18.55% above the market average18.55% above the market average18.55% above the market average
17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average
Buys 1y
70.8% below the market average70.8% below the market average70.8% below the market average70.8% below the market average70.8% below the market average
47.83% below the sector average47.83% below the sector average47.83% below the sector average47.83% below the sector average47.83% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 129.00p
Change Today -4.00p
% Change -3.01 %
52 Week High 150.00
52 Week Low 108.00
Volume 101,152
Shares Issued 84.81m
Market Cap £109.40m
Beta 0.00
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.14% below the market average33.14% below the market average33.14% below the market average33.14% below the market average33.14% below the market average
57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average
Price Trend
55.19% above the market average55.19% above the market average55.19% above the market average55.19% above the market average55.19% above the market average
67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average
Income Not Available
Growth
41.02% above the market average41.02% above the market average41.02% above the market average41.02% above the market average41.02% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

Diaceutics Dividends

No dividends found

Trades for 06-Jun-2025

Time Volume / Share Price
15:27 10,000 @ 130.00p
15:22 10,000 @ 127.99p
15:13 10,000 @ 127.68p
14:03 2,000 @ 127.00p
14:02 5,000 @ 127.03p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page